News
Published over 16 years ago. See the latest and most current information on News.
The Automation Partnership (TAP) is to continue its partnership with the EPSRC Centre for Innovative Manufacturing in Regenerative Medicine at Loughborough for a second five year phase. This follows the recent announcement by Prime Minister, Gordon Brown and Lord Mandelson, UK Secretary of State, Department for Business, Innovation and Skills of a £5.33 million grant to the centre.
The new partnership will mean further development and testing of the CompacT CellBase™ system for culturing clinically applicable stem cells in a GMP environment and to begin new research with the centre to develop
ambr™, TAP’s microscale bioreactor.
This collaboration is a continuation of the work TAP began as part of the remedi (regenerative medicine – a new industry) EPSRC Grand Challenge consortium in 2005 and has contributed to remedi achieving three world
firsts in automated cell culture, including production in a CompacT CellBase of a clinical grade neuronal stem cell line.
ILM Guide 2026/27